Evaluating guidelines on continuation of anti-tumour necrosi…
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months%3A clinical effectiveness and costs of observed care and different alternative strategies.
Article, Chapter
Authors:
W. Kievit
Publication:
Volume:68,
Issue:6,
Page(s):844-849
Published:
2009
We were unable to find direct full text links for this item.